Stutsky explains why shifting therapy perceptions had more pharmacist touchpoints and longer time on therapy among patients with ATTR-CM.
Martha Stutsky, PharmD, BCPS
Advertisement
Martha Stutsky, PharmD, BCPS, director of clinical outcomes. Shields Health Solutions
Articles by Martha Stutsky, PharmD, BCPS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Postvaccine Hepatitis Reports More Often Serious in Children vs Adults
2
CMS Moves TIC Reporting to Quarterly, Sets Drug File Timeline
3
Predoc and Nebraska Cancer Specialists: Not Letting the Fax Be the Fumble
4
Up to 400 mg of Caffeine Daily Is Safe for Most Adults, AHA Says
5